CY1115168T1 - Πεπτιδια fviii και η χρηση τους στην επαγωγη ανοχης των αιμορροφιλικων - Google Patents
Πεπτιδια fviii και η χρηση τους στην επαγωγη ανοχης των αιμορροφιλικωνInfo
- Publication number
- CY1115168T1 CY1115168T1 CY20141100281T CY141100281T CY1115168T1 CY 1115168 T1 CY1115168 T1 CY 1115168T1 CY 20141100281 T CY20141100281 T CY 20141100281T CY 141100281 T CY141100281 T CY 141100281T CY 1115168 T1 CY1115168 T1 CY 1115168T1
- Authority
- CY
- Cyprus
- Prior art keywords
- hemomorphics
- inducing tolerance
- fviii peptides
- peptide
- peptides
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 102100026735 Coagulation factor VIII Human genes 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 201000003542 Factor VIII deficiency Diseases 0.000 abstract 1
- 208000013633 acquired hemophilia Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 102000057593 human F8 Human genes 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0723712.6A GB0723712D0 (en) | 2007-12-04 | 2007-12-04 | Peptides |
| EP08855772.3A EP2227488B3 (en) | 2007-12-04 | 2008-12-03 | Fviii peptides and their use in tolerising haemophiliacs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1115168T1 true CY1115168T1 (el) | 2016-12-14 |
Family
ID=38982965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20141100281T CY1115168T1 (el) | 2007-12-04 | 2014-04-15 | Πεπτιδια fviii και η χρηση τους στην επαγωγη ανοχης των αιμορροφιλικων |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8445448B2 (enExample) |
| EP (1) | EP2227488B3 (enExample) |
| JP (2) | JP5501245B2 (enExample) |
| KR (1) | KR101519840B1 (enExample) |
| CN (2) | CN103709234B (enExample) |
| AU (1) | AU2008332968B2 (enExample) |
| BR (1) | BRPI0820143A2 (enExample) |
| CA (2) | CA3005013C (enExample) |
| CY (1) | CY1115168T1 (enExample) |
| DK (1) | DK2227488T6 (enExample) |
| EA (1) | EA019370B1 (enExample) |
| EC (1) | ECSP10010327A (enExample) |
| ES (1) | ES2458315T7 (enExample) |
| GB (1) | GB0723712D0 (enExample) |
| HR (1) | HRP20140344T4 (enExample) |
| IL (1) | IL205780A (enExample) |
| MX (1) | MX2010006084A (enExample) |
| MY (1) | MY150995A (enExample) |
| NZ (1) | NZ585217A (enExample) |
| PL (1) | PL2227488T6 (enExample) |
| PT (1) | PT2227488E (enExample) |
| SI (1) | SI2227488T1 (enExample) |
| UA (1) | UA101003C2 (enExample) |
| WO (1) | WO2009071886A1 (enExample) |
| ZA (1) | ZA201002997B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1311542T1 (sl) | 2000-08-21 | 2009-02-28 | Apitope Technology Bristol Ltd | Tolerogenski peptidi |
| GB0801513D0 (en) * | 2008-01-28 | 2008-03-05 | Circassia Ltd | Peptides from factor VIII |
| SI2300497T1 (sl) * | 2008-06-24 | 2013-02-28 | Octapharma Ag | Postopek za äťiĺˇäťenje koagulacijskega faktorja viii |
| GB0908515D0 (en) * | 2009-05-18 | 2009-06-24 | Apitope Technology Bristol Ltd | Peptide |
| US20120135917A1 (en) * | 2009-06-16 | 2012-05-31 | Eisaku Yoshihara | Anti-Gram Negative Bacteria Agent |
| DK2632479T3 (en) * | 2010-10-27 | 2017-08-07 | Baxalta GmbH | FVIII PEPTIDES FOR IMMUNT TOLERANCE INDUCTION AND IMMUNODIAGNOSTICS |
| PL3453402T3 (pl) | 2012-01-12 | 2022-03-21 | Bioverativ Therapeutics Inc. | Zmniejszenie immunogenności przeciwko czynnikowi viii u osób poddawanych terapii czynnikiem viii |
| PL2917232T3 (pl) * | 2012-11-12 | 2017-09-29 | Apitope International Nv | Pochodzące od czynnika VIII peptydy do zastosowania w leczeniu hemofilii A |
| GB201314052D0 (en) | 2013-08-06 | 2013-09-18 | Apitope Int Nv | Peptides |
| WO2017096329A1 (en) | 2015-12-03 | 2017-06-08 | Juno Therapeutics, Inc. | Modified chimeric receptors and related compositions and methods |
| BR112019011198A2 (pt) | 2016-12-02 | 2019-12-17 | Bioverativ Therapeutics Inc | métodos de indução de tolerância imune a fatores de coagulação |
| US12077607B2 (en) * | 2021-09-23 | 2024-09-03 | University Of Utah Research Foundation | Functional and therapeutic effects of PAR4 cleavage by cathepsin G |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT94427A (pt) | 1989-06-20 | 1991-03-20 | Scripps Clinic Res | Processo para a preparacao de polipeptidos que inibem a ligacao de factor viii humano a fosfolipidos |
| BR9806793A (pt) * | 1997-01-22 | 2000-05-16 | Univ Texas | Processos e composições de fator tissular para coagulação e tratamento de tumores. |
| SI1311542T1 (sl) * | 2000-08-21 | 2009-02-28 | Apitope Technology Bristol Ltd | Tolerogenski peptidi |
| US20040096456A1 (en) * | 2000-12-01 | 2004-05-20 | Conti-Fine Bianca M | Method to treat hemophilia |
| AU2002233340B2 (en) * | 2001-02-19 | 2008-05-22 | Merck Patent Gmbh | Artificial fusion proteins with reduced immunogenicity |
| AU2002312660A1 (en) * | 2001-05-31 | 2002-12-16 | D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven | Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools |
| JP2005538694A (ja) * | 2002-04-18 | 2005-12-22 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | 修飾されたｖｉｉｉ因子 |
| SI1729795T1 (sl) * | 2004-02-09 | 2016-04-29 | Human Genome Sciences, Inc. | Albuminski fuzijski proteini |
| WO2006003183A1 (de) | 2004-07-02 | 2006-01-12 | Alois Jungbauer | Peptide zur blockierung von fviii-inhibitoren |
| IL229645A0 (en) * | 2013-11-26 | 2014-03-31 | Omrix Biopharmaceuticals Ltd | A dry bandage containing thrombin and pectin |
-
2007
- 2007-12-04 GB GBGB0723712.6A patent/GB0723712D0/en not_active Ceased
-
2008
- 2008-03-12 UA UAA201008194A patent/UA101003C2/uk unknown
- 2008-12-03 SI SI200831186T patent/SI2227488T1/sl unknown
- 2008-12-03 CN CN201310392152.6A patent/CN103709234B/zh not_active Expired - Fee Related
- 2008-12-03 NZ NZ585217A patent/NZ585217A/xx not_active IP Right Cessation
- 2008-12-03 EA EA201070681A patent/EA019370B1/ru not_active IP Right Cessation
- 2008-12-03 KR KR1020107011743A patent/KR101519840B1/ko not_active Expired - Fee Related
- 2008-12-03 US US12/746,141 patent/US8445448B2/en not_active Expired - Fee Related
- 2008-12-03 HR HRP20140344TT patent/HRP20140344T4/hr unknown
- 2008-12-03 AU AU2008332968A patent/AU2008332968B2/en not_active Ceased
- 2008-12-03 PT PT88557723T patent/PT2227488E/pt unknown
- 2008-12-03 ES ES08855772.3T patent/ES2458315T7/es active Active
- 2008-12-03 PL PL08855772T patent/PL2227488T6/pl unknown
- 2008-12-03 CN CN200880119313.1A patent/CN101889024B/zh not_active Expired - Fee Related
- 2008-12-03 CA CA3005013A patent/CA3005013C/en active Active
- 2008-12-03 DK DK08855772.3T patent/DK2227488T6/en active
- 2008-12-03 WO PCT/GB2008/003996 patent/WO2009071886A1/en not_active Ceased
- 2008-12-03 EP EP08855772.3A patent/EP2227488B3/en active Active
- 2008-12-03 JP JP2010536523A patent/JP5501245B2/ja active Active
- 2008-12-03 MY MYPI20102567 patent/MY150995A/en unknown
- 2008-12-03 CA CA2707559A patent/CA2707559C/en active Active
- 2008-12-03 MX MX2010006084A patent/MX2010006084A/es active IP Right Grant
- 2008-12-03 BR BRPI0820143 patent/BRPI0820143A2/pt not_active Application Discontinuation
-
2010
- 2010-04-29 ZA ZA2010/02997A patent/ZA201002997B/en unknown
- 2010-05-13 IL IL205780A patent/IL205780A/en active IP Right Grant
- 2010-07-02 EC EC2010010327A patent/ECSP10010327A/es unknown
-
2014
- 2014-02-10 JP JP2014023217A patent/JP6063402B2/ja not_active Expired - Fee Related
- 2014-04-15 CY CY20141100281T patent/CY1115168T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1115168T1 (el) | Πεπτιδια fviii και η χρηση τους στην επαγωγη ανοχης των αιμορροφιλικων | |
| CY1122458T1 (el) | Αντισωματα αντι-n3pglu αμυλοειδους βητα πεπτιδιου και χρησεις αυτων | |
| CY1115999T1 (el) | Νεα και ισχυρα mhc- κατηγοριας ιι πεπτιδια που προερχονται απο σουρβιβινη και νευροκανη | |
| CY1121962T1 (el) | Υποδοχεις τ κυτταρου | |
| CY1122235T1 (el) | Καινοτομος ανοσοθεραπεια εναντι διαφορων ογκων συμπεριλαμβανομενου του γαστρεντερικου και του γαστρικου καρκινου | |
| CY1119789T1 (el) | Cgrp αντισωματα | |
| CY1122677T1 (el) | Καινοτομος ανοσοθεραπεια εναντι ορισμενων ογκων συμπεριλαμβανομενων ογκων των νευρωνων και του εγκεφαλου | |
| CY1121632T1 (el) | Η rv2386c πρωτεϊνη φυματιωσης, συνθεσεις και χρησεις αυτης | |
| EA201000207A1 (ru) | Новые иммуногенные эпитопы для иммунотерапии | |
| CY1119647T1 (el) | Αντισωματα προσδεσης αλβουμινης και τμηματα προσδεσης αυτων | |
| CY1124950T1 (el) | Καινοτομος ανοσοθεραπεια εναντι διαφορων ογκων, οπως του καρκινου του πνευμονα συμπεριλαμβανομενου του μμκπ | |
| EA201270313A1 (ru) | Композиции, которые индуцируют хелперное действие т-клеток | |
| CY1120352T1 (el) | Ανοσοθεραπεια βασισμενη στη 2,3 διοξυγοναση της ινδολεαμινης | |
| CY1118492T1 (el) | Φαρμακοτεχνικες μορφες εμβολιου norovirus | |
| CY1118994T1 (el) | Πρωτεϊνες συνδεσης αντιγονου il-17 υποδοχεα α | |
| CY1116828T1 (el) | Πεπτιδια για απευαισθητοποιηση απο αλλεργιογονα | |
| CL2008000104A1 (es) | Proteina de fusion que comprende un antigeno asociado a tumor (prame) o un fragmento inmunogenico de el y un derivado de proteina d; secuencia nucleotidica que codifica dicha proteina; vector y celula huesped que comprenden la proteina; vacuna que co | |
| CY1120212T1 (el) | Πεπτιδια | |
| CY1115832T1 (el) | Πεπτιδια που προερχονται απο fviii και η χρηση τους στην επαγωγη ανοχης των αιμορροφιλικων | |
| CY1119164T1 (el) | Πεπτιδια που προερχονται απο τον παραγοντα viii για χρηση στη θεραπεια της αιμορροφιλιας α | |
| EA201390811A1 (ru) | Пептиды tomm34 и содержащие их вакцины | |
| CY1117265T1 (el) | Αντισωματα aνti-n3pglu αμυλοειδους βητα πεπτιδιου και χρησεις αυτων | |
| CY1110086T1 (el) | Πεπτιδια καρκινικου αντιγονου προερχομενα απο wt1 | |
| CY1116819T1 (el) | Καινοτομος ανοσοθεραπεια εναντι διαφορων ογκων συμπεριλαμβανομενου του γαστρεντερικου και γαστρικου καρκινου | |
| CY1115000T1 (el) | Ανθρωπινα αντισωματα εναντια στη λυσσα και χρησεις αυτων |